(Q41759700)

9 October 2017

title

A simple cost-decision analysis model comparing two strategies for hepatitis A vaccination (English)

1 reference

9 October 2017

1 reference

1 reference

Saab S

1

1 reference

9 October 2017

Martin P

series ordinal

2

1 reference

9 October 2017

Yee HF Jr

series ordinal

3

1 reference

9 October 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

American Journal of Medicine

9 October 2017

published in

1 reference

9 October 2017

volume

109

1 reference

9 October 2017

issue

3

1 reference

9 October 2017

page(s)

241-244

1 reference

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

9 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900469-1

Two-year review of hepatitis A vaccine safety: data from the Vaccine Adverse Event Reporting System (VAERS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900469-1

Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900469-1

Seroprevalence of and risk factors for hepatitis A infection among young homosexual and bisexual men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900469-1

Hepatitis A among homosexual men and injection drug users: more evidence for vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900469-1

Sexual transmission of hepatitis A in homosexual men: incidence and mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900469-1

Increased Risk of Infection with Hepatitis A and B Viruses in Men with a History of Syphilis: Relation to Sexual Contacts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900469-1

Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900469-1

Clinical experience with an inactivated hepatitis A vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900469-1

10.1016/S0002-9343(00)00469-1

7 January 2021

Identifiers

DOI

1 reference

9 October 2017

1 reference